In vitro leishmanicidal activity of monomeric and dimeric naphthoquinones

Acta Tropica

Volumn 76, Issue 2, 2000, Pages 131-138

  Kayser, Oliver ^a   Kiderlen, Albrecht F ^b   Laatsch, Hartmut ^c   Croft, Simon L ^d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c Institute of Organic Chemistry   (Germany)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antiprotozoal; In vitro; Leishmania; Naphthoquinones

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 (DIPHENYLMETHYL)NAPHTHOQUINONE; 2,3 DIMETHYLNAPHTHAZARIN; 3,3' BIJUGLONE; 3,3' BIPLUMBAGINE; 5,5' DIMETHYL 2,2' BIAPHTHOQUINONE; 5,6,7,8 TETRAHYDROQUINIZARIN; 6,6' DIBENZYLOXY 3,3' BIPLUMBAGIN; 6,6',7,7' TETRAETHOXY 2,2' BINAPHTHOQUINONE; 9,9',10,10' TETRAMETHOXY[2,2' BIANTHRYL] 1,4;1',4' DIQUINONE; AMPHOTERICIN B; BRASANQUINONE; DINAPHTHO[2,3;1',2' D]FURAN 5,13;11,12 DIQUINONE; MAMEGAKINONE; PENTAMIDINE ISETHIONATE; PLUMBAGIN; UNCLASSIFIED DRUG; XANTHOMEGNIN;

DRUG PRESCRIBING; LEISHMANIASIS; TOXICITY;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MACROPHAGE; MOUSE; NONHUMAN; PROMASTIGOTE;

ANIMALS; HUMANS; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA ENRIETTII; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGES; NAPHTHOQUINONES; TUMOR CELLS, CULTURED;

ANIMALIA; LEISHMANIA DONOVANI; LEISHMANIA ENRIETTII; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MAMMALIA; MURINAE; PROTOZOA;

EID: 0034684055     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(00)00078-4     Document Type: Article

References (36)

1. Abdi Y.A., Gustafson L.L., Ericson O., Heligren T. Handbook of Drugs for Tropical Parasitic Infections. 1995;Taylor and Francis, Oxford, London.
2. Brockmann H., Müller K. Über die Synthese des Alkannans und anderer Alkylnaphtazine. Liebigs Ann. Chem. 540:1939;51-62.
3. Brockmann H., Laatsch H. Regioselektive Synthesen von 3,3′-Bijuglon, Marnegakinon, Dianellion, cyclo-Trijuglon, Xyclosporin und Trianelliondurch Phenol/Chinon-Addition. Liebigs Ann. Chem. 1983:1983;433-447.
4. Channon J.Y., Roberts M.R., Blackwell J.M. A study of the differential respiratory burst elicited by promastigote and amastigote Leishmania donovani in murine peritoneal macrophages. Immunology. 53:1984;345-355.
5. Croft S.L., Evans A.T., Neal R.A. The activity of plumbagin and other electron carriers against Leishmania dononani and Leishmania mexicana. Ann. Trop. Med. Parasitol. 79:1985;651-653.
6. Croft S.L., Hogg J., Gutteridge W.E., Hudson A.T., Randall A.W. The activity of hydroxynaphthoquinones against Leishmania donovani. J. Antimicrob. Chemother. 30:1992;827-832.
7. Ellis J.E. Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitol. Today. 10:1994;296-301.
8. Fournet A, Angelo A., Munoz V., Roblot F, Hocquemiller R., Cava A. Biological and chemical studies of Pera benensis, a Bolivian plant used in folk medicine as a treatment of cutaneous leishmaniasis. J. Ethnopharmacol. 37:1992;159-164.
9. Fry M., Pudney M. Site of action of the antimalarial hydroxynaphthoquinone 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem. Pharmacol. 43:1992;1545-1553.
10. Hart D.T., Coombs G.H. Leishmania mexicana: energy metabolism of amastigotes and promastigotes. Exp. Parasitol. 54:1982;397-409.
11. Hazra B., Pal S., Banerjee A. New diospyrin derivatives with improved inhibitory activity towards Ehrlich ascites carcinoma. Med. Sci. Res. 22:1992;351-353.
12. Hudson A.T., Randall A.W., Fry M. et al. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology. 90:1985;45-55.
13. Hudson A.T., Dickins M., Ginger C.D. et al. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp. Clin. Res. 17:1991;427-435.
14. Hudson A.T. Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol. Today. 9:1993;66-68.
15. lwu M.M., Jackson J.E., Schuster B.G. Medicinal plants in the fight against leishmaniasis. Parasitol. Today. 10:1994;65-68.
16. Jones, P.G., 1966. Thermal decomposition of the diphenyidiazomethane adducts of 1,4-naphthoquinone. Chem. Commun. 894-895.
17. Kayser O., Kiderlen A.F., Folkens U., Kolodziej H. In vitro leishmanicidal activity of aurones. Planta Med. 65:1999;316-319.
18. Kiderlen A.F., Kaye P.M. A modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites. J. Immunol. Methods. 127:1990;11-18.
19. Laatsch H. Dimere Naphthochinone, IV. Synthese von Bivametaceon, Mamegakinon und Rotundichinon. Liebigs Ann. Chem. 1980:1980;321-1347.
20. Laatsch H. Dimere Naphthochinone, IX. Isodiospyrin und Elliptinon-Synthese 6,6′-dimerer Bijuglone durch Phenoloxidation. Liebigs Ann. Chem. 1984:1984;319-339.
21. Laatsch H. Dimere Naphthoquinone, X. Ein neuartiger Syntheseweg Desapogossypelan-tetraethylether. Z. Naturforsch. 3913:1984;244-247.
22. Laatsch H. Dimere Naphthochinone, XII. Über die Selektivität der Addition von Diazomethan an benzoid-substituierte 1,4-Naphthochinone. Liebigs Ann. Chem. 1985:1985;251-274.
23. Laatsch H. Dimere Naphthochinone, IX. Synthese von Diomelchinon A und seinen Dimeren, 7,7′-Dihydroxy-8,8′-dimethoxy-3,3′-dimethyi-2,2′-bi-1,4- naphthochinon. Liebigs Ann. Chem. 1985:1985b;1847-1865.
24. Laatsch H. Synthese dimerer und cyclo-trimerter 1,4-Anthrachinone. Liebigs Ann. Chem. 1986:1986;839-858.
25. Laatsch H. Methylierung 3,3′-dihydroxylierter 2,2′-Binaphthyl-1,4; 1′,4′, dichinone. Z. Naturforsch. 45B:1990;393-400.
26. Mauël, I., Behin, R., Biroum-Noerjasin, Rowe, D.S., 1975. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages. Clin. Exp. Immunol. 20, 339-350.
27. Meinicke C.K., Schottelius J., Oskam L., Fleischer B. Subclinically infected mothers can serve as reservoir for congenital transmission of visceral leishmaniasis: first case report in review of the literature. Acta Parasitol. Turcica. 21(Suppl. 1):1997;55-156.
28. Molina Portela M.P., Fernandez Villamil S.H., Perissimotti L.J., Stoppani A.O.M. Redox cycling of o-naphthoquinones in trypanosomatids. Biochem. Pharmacol. 52:1996;1875-1882.
29. Müller L., Freudenberg M., Kropf P., Kiderlen A.F., Galanos C. Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenoptype. Med. Microbiol. Immunol. 186:1997;75-81.
30. Neal R.A., Croft S.L. An in vitro system for determining theactivity of compounds against the intracellular form of Leishmania donovani. J. Antimicrob. Chemother. 14:1984;463-475.
31. Parker K.A., Kallmerten J. Approaches to anthracyclines. 2. Regiospecific annelative quinine synthesis. J. Org. Chem. 45:1980;2620-2625.
32. Sepúvelda-Boza S., Cassels B.K. Plant metabolites active against Trypanosoma cruzi. Planta Med. 62:1996;98-105.
33. Shand A.J., Thomson R.H. Diquinones II: the formation of dibenzofuran derivatives by rearrangement of diquinones: tetrahedron dibenzofuran derivatives by rearrangement of diquinones. Tetrahedron. 19:1963;1919-1920.
34. Van Hellemond J.J., Van der Mer P., Tielens A.G.M. Leishmania infantum promastigotes have a poor capacity for anaerobic functioning and depend mainly on respiration for their energy generation. Parasitology. 114:1997;351-360.
35. Yardley V., Snowdon D., Croft S.L., Hazra B. In vitroactivity of diospyrin and derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei brucei. Phytotherap. Res. 10:1996;559-562.
36. Zeeck A., Rug P., Laatsch H. et al. Stoffwechselprodukte von Mikroorganismen, 172. Mitteilung, Isolierung des Antibioticums semi-Vioxanthin aus Penicillium citreo-viride und Synthese des Xanthomegnins. Chem. Ber. 112:1979;957-978.